Variability of Clinician Recommendations for Oseltamivir in Children Hospitalized With Influenza
Our results demonstrate nonadherence to national recommendations and variability in oseltamivir treatment for children hospitalized with influenza, indicating uncertainty and disagreement regarding which patients benefit from antivirals. A randomized controlled trial of oseltamivir in hospitalized children is needed to help strengthen current influenza treatment recommendations and inform clinicians of treatment benefit in specific pediatric populations.
Authors
- Danni Liang (ORCID: https://orcid.org/0000-0002-3116-4396)
- Jimmy Beck (ORCID: https://orcid.org/0000-0002-8499-6444)
- Ricardo A. Quinonez
- Ravi R. Jhaveri (ORCID: https://orcid.org/0000-0001-9921-0419)
- Brian Lucas (ORCID: https://orcid.org/0000-0002-0687-2139)
- Suchitra Rao (ORCID: https://orcid.org/0000-0002-0334-6301)
- Patrick W. Brady (ORCID: https://orcid.org/0000-0002-7078-3077)
- Alan R. Schroeder (ORCID: https://orcid.org/0000-0002-9725-3279)
- Torsten Joerger (ORCID: https://orcid.org/0000-0002-1915-4275)
- Hannah K. Bassett (ORCID: https://orcid.org/0000-0002-0581-1502)
- J Malec (ORCID: https://orcid.org/0009-0000-6947-953X)
- Alaina Shine
Institutions
- Northwestern University (US)
- Dartmouth Institute for Health Policy and Clinical Practice (US)
- Baylor College of Medicine (US)
- University of Washington (US)
- Stanford Medicine (US)
- Texas Children's Hospital (US)
- University of Pennsylvania (US)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- PEDIATRICS
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1542/peds.2024-069111
- Citations
- 4
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.42